BranchOut Food Inc. Signs LOI and receives $250K PO from Leading Ingredient Distributor, Definitive Agreement Targeting $5-6M in 2025 Ingredient Sales
Projecting $4.0M in net revenue for Q1 2025—up 170% from the prior year—and expects to achieve positive cash flow in the same quarter Key Highlights: Signed LOI with leading ingredient distributor, establishing immediate sales volume in the ingredient channel....
Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
IRVINE, Calif., Dec. 04, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta Neuropathologica...
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative...
AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business
NEW YORK, Dec. 03, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company entered into Repurchase Agreements with four shareholders, all non-affiliates of...
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec. 03, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious...
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific...
Halberd Update on WatchDawg® PTSD Treatment
Next Phase Pilot Study Jackson Center, PA, December 2, 2024 - PRISM MediaWire - Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal...
StemSation International Announces Acquisition of Gorilla Marketing Group, LLC
StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC Strategic Acquisition Completed: StemSation International has finalized the acquisition of Gorilla Marketing Group (GMG),...
Skyborne Technology, Inc., a UAV Corp Company (UMAV) and Atlantic Industrial Group Inc. (AIG) Announce AI Manufacturing JV for VTOL & Lighter than Air Vehicles
Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of New Hangar Cutting-Edge Manufacturing: AIG will produce high-efficiency drone models (SVTOLs) at Skyborne’s facility, leveraging innovative manufacturing techniques...
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024
Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET on December 3, 2024, and Engage in Investor Meetings Throughout the Conference MIAMI, Nov. 27, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"),...